Peakstone Realty Trust 8-K

What Happened

• Peakstone Realty Trust (PKST) announced that shareholders approved the Agreement and Plan of Merger dated February 2, 2026, with affiliates of Brookfield Strategic Real Estate Partners V (BSREP V) at a special meeting held April 29, 2026. Under the agreement, an Operating Merger (merging PKST OP, L.P.’s buyer subsidiary into the Operating Partnership) will be followed immediately by a Company Merger (merging the REIT Merger Sub into the Company), with the Company surviving.
• As of the March 13, 2026 record date there were 37,187,359 common shares outstanding; 22,441,754 shares (≈60.34%) were present or represented by proxy, constituting a quorum. The Merger Proposal (Proposal 1) was approved: For 21,848,801; Against 304,887; Abstain 288,066.

Key Details

• Merger agreement date: February 2, 2026; related proxy filed March 16, 2026.
• Record date / outstanding shares: March 13, 2026 / 37,187,359 common shares.
• Votes at special meeting (April 29, 2026): 22,441,754 shares present (≈60.34%).
• Proposal votes:
  • Proposal 1 (approve Company Merger & related transactions): For 21,848,801; Against 304,887; Abstain 288,066.
  • Proposal 2 (non‑binding advisory vote on executive compensation related to the Mergers): For 16,360,800; Against 5,655,446; Abstain 425,508.
  • Proposal 3 (approve adjournment if needed): For 20,966,414; Against 1,127,090; Abstain 348,250. Adjournment was not needed.

Why It Matters

• The shareholder approval clears a key vote required for the transaction to proceed toward closing under the Merger Agreement, subject to the other closing conditions in that agreement. This is a material corporate event for PKST investors because it signals management and a majority of shareholders support the proposed combination.
• The advisory (non‑binding) vote on executive compensation also passed, but being non‑binding it does not itself change contract terms. Investors should watch future SEC filings for closing updates, transaction timing, and any additional conditions or regulatory approvals.